Intrinsic Value of S&P & Nasdaq Contact Us

Roche Holding AG RHHBF OTC

Other OTC • Healthcare • Drug Manufacturers - General • CH • USD

SharesGrow Score
67/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Roche Holding AG (RHHBF) reported total assets of $100.75B and total liabilities of $62.85B for quarter ending 2025-12-31, resulting in total equity of $37.9B.

The company held $15.48B in cash and short-term investments. Total debt stood at $34.45B, with net debt of $28.87B. The Debt-to-Equity (D/E) ratio was 0.91 (moderate).

Current ratio is 1.38, suggesting adequate short-term liquidity. Interest coverage is 9.6x (strong).

Criteria supported by this page:

  • HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
  • MOAT (94/100) — Total assets $100.75B and equity $37.9B support the company's competitive scale
  • VALUE (60/100) — Debt-to-Equity 0.91 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 67/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
67/100
SG Score
View full scorecard →
VALUE
60/100
Price-to-Earnings & upside
→ Valuation
FUTURE
20/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
94/100
Proven by this page
~
GROWTH
40/100
→ Income
INCOME
85/100
→ Income
Roche Holding AG Balance Sheet History
Metric Q4 FY2025 Q2 FY2025 Q4 FY2024 Q2 FY2024
Total Assets $100.75B$94.77B$101.8B$95.79B
Total Liabilities $62.85B$61.72B$65.64B$62.91B
Total Debt $34.45B$34.63B$36.35B$36.18B
Cash & Investments $15.48B$12.03B$17.32B$8.81B
Total Stockholders Equity $33.82B$28.68B$31.77B$28.94B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message